Nasser Hanna

  • 8113 Citations
  • 41 h-Index
19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

2020

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14-179

Durm, G. A., Jabbour, S. K., Althouse, S. K., Liu, Z., Sadiq, A. A., Zon, R. T., Jalal, S. I., Kloecker, G. H., Williamson, M. J., Reckamp, K. L., Langdon, R. M., Kio, E. A., Gentzler, R. D., Adesunloye, B. A., Harb, W. A., Walling, R. V., Titzer, M. L. & Hanna, N. H., Oct 1 2020, In : Cancer. 126, 19, p. 4353-4361 9 p.

Research output: Contribution to journalArticle

High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases

Kalra, M., Adra, N., Hanna, N., Abonour, R. & Einhorn, L. H., Mar 15 2020, In : Cancer. 126, 6, p. 1202-1207 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

Lung Cancer Screening Knowledge Among Internal Medicine Residents in a University Program

Urrutia Argueta, S. & Hanna, N., Jan 1 2020, (Accepted/In press) In : Journal of Cancer Education.

Research output: Contribution to journalArticle

3 Scopus citations

Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): A prospective phase I study protocol

McClelland, S., Lautenschlaeger, T., Zang, Y., Hanna, N. H., Shiue, K., Kamer, A. P., Agrawal, N., Ellsworth, S. G., Rhome, R. M. & Watson, G. A., Jul 1 2020, In : Reports of Practical Oncology and Radiotherapy. 25, 4, p. 500-506 7 p.

Research output: Contribution to journalReview article

Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell Tumors

Zhang, K. J., Hanna, N. H., Althouse, S. K., Zaid, M. A., Abonour, R., Albany, C., Einhorn, L. H. & Adra, N., Oct 2020, In : Clinical Genitourinary Cancer. 18, 5, p. e585-e587

Research output: Contribution to journalComment/debate

The case for maintenance pemetrexed plus bevacizumab

Hanna, N. & Jalal, S., Mar 1 2020, In : Journal of Clinical Oncology. 38, 7, p. 770-771 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy

Khanal, N., Ahmed, S. S., Kalra, M., Miller, T. J., Brames, M. J., Stump, T. E., Monahan, P., Hanna, N. H. & Einhorn, L. H., Jul 1 2020, In : Supportive Care in Cancer. 28, 7, p. 3165-3170 6 p.

Research output: Contribution to journalArticle

Therapy for stage IV non–small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update

Hanna, N. H., Schneider, B. J., Temin, S., Baker, S., Brahmer, J., Ellis, P. M., Gaspar, L. E., Haddad, R. Y., Hesketh, P. J., Jain, D., Jaiyesimi, I., Johnson, D. H., Leighl, N. B., Phillips, T., Riely, G. J., Robinson, A. G., Rosell, R., Schiller, J. H., Singh, N., Spigel, D. R. & 3 others, Stabler, J. O., Tashbar, J. & Masters, G., 2020, In : Journal of Clinical Oncology. 38, 14, p. 1608-1632 25 p.

Research output: Contribution to journalArticle

19 Scopus citations

Therapy for stage IV Non–small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update summary

Hanna, N. H., Temin, S. & Masters, G., 2020, In : JCO Oncology Practice. 16, 8, p. E844-E848

Research output: Contribution to journalArticle

The Story of Angiogenesis Inhibitors in Non–small-cell Lung Cancer: The Past, Present, and Future

Shukla, N. A., Yan, M. N. & Hanna, N., Jul 2020, In : Clinical Lung Cancer. 21, 4, p. 308-313 6 p.

Research output: Contribution to journalReview article

1 Scopus citations
2019
5 Scopus citations

Predicting progression of in situ carcinoma in the era of precision genomics

Cheng, M., Hanna, N. H., Davidson, D. D. & Gunderman, R. B., Jun 1 2019, In : Journal of Thoracic Disease. 11, 6, p. 517-525 9 p.

Research output: Contribution to journalReview article

The shifting paradigm of biomarker-driven care in advanced non-small cell lung cancer (NSCLC)

Durm, G. & Hanna, N., 2019, In : Translational Lung Cancer Research. 8, 4, p. 539-542 4 p.

Research output: Contribution to journalReview article

2018
3 Scopus citations

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Use for Subclassification and Genotyping of Lung Non-Small-Cell Carcinoma

Raad, S., Hanna, N., Jalal, S., Bendaly, E., Zhang, C., Nuguru, S., Oueini, H. & Diab, K., Aug 1 2018, In : Southern Medical Journal. 111, 8, p. 484-488 5 p.

Research output: Contribution to journalArticle

1 Scopus citations
6 Scopus citations

Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors

Albany, C., Adra, N., Snavely, A. C., Cary, C., Masterson, T. A., Foster, R. S., Kesler, K., Ulbright, T. M., Cheng, L., Chovanec, M., Taza, F., Ku, K., Brames, M. J., Hanna, N. H. & Einhorn, L. H., Feb 1 2018, In : Annals of Oncology. 29, 2, p. 341-346 6 p.

Research output: Contribution to journalArticle

33 Scopus citations

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: A Hoosier Cancer Research Network Study GU14-206

Adra, N., Einhorn, L. H., Althouse, S. K., Ammakkanavar, N. R., Musapatika, D., Albany, C., Vaughn, D. & Hanna, N. H., Jan 1 2018, In : Annals of Oncology. 29, 1, p. 209-214 6 p.

Research output: Contribution to journalArticle

57 Scopus citations

Reply to M.E.H.M. Van Hoef

Hanna, N., Temin, S., Oliver, T. K. & Masters, G., Feb 1 2018, In : Journal of Clinical Oncology. 36, 4, 1 p.

Research output: Contribution to journalLetter

Reply to the letter to the editor 'A centralised multidisciplinary clinic approach for germ cell tumours' by Crawford

Albany, C., Adra, N., Snavely, A., Cary, C., Masterson, T., Foster, R., Kesler, K., Ulbright, T., Cheng, L., Chovanec, M., Taza, F., Hanna, N. & Einhorn, L., Jan 1 2018, In : Annals of Oncology. 29, 11, p. 2264-2265 2 p.

Research output: Contribution to journalLetter

5 Scopus citations

Second-Line Treatment Options in Non–Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology

Gridelli, C., Baas, P., Barlesi, F., Ciardiello, F., Crinò, L., Felip, E., Gadgeel, S., Papadimitrakopoulou, V., Paz-Ares, L., Planchard, D., Perol, M., Hanna, N., Sgambato, A., Casaluce, F. & de Marinis, F., Jul 2018, In : Clinical Lung Cancer. 19, 4, p. 301-314 14 p.

Research output: Contribution to journalReview article

5 Scopus citations

Understanding lung cancer screening behavior: Racial, gender, and geographic differences among Indiana long-term smokers

Carter-Harris, L., Slaven, J. E., Monahan, P. O., Shedd-Steele, R., Hanna, N. & Rawl, S. M., Jun 2018, In : Preventive Medicine Reports. 10, p. 49-54 6 p.

Research output: Contribution to journalArticle

20 Scopus citations
2017

A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113

Sanborn, R. E., Patel, J. D., Masters, G. A., Jayaram, N., Stephens, A., Guarino, M., Misleh, J., Wu, J. & Hanna, N., Jan 1 2017, In : Cancer. 123, 2, p. 303-311 9 p.

Research output: Contribution to journalArticle

14 Scopus citations

Can radiotherapy potentiate the effectiveness of immune checkpoint inhibitors in lung cancer?

Cheng, M., Durm, G., Hanna, N., Einhorn, L. H. & Kong, F. M., Dec 2017, In : Future Oncology. 13, 28, p. 2503-2505 3 p.

Research output: Contribution to journalEditorial

5 Scopus citations

Case for stopping targeted therapy when lung cancer progresses on treatment in hospice- eligible patients

Smith, T. J., Hanna, N., Johnson, D., Baker, S., Biermann, W. A., Brahmer, J., Ellis, P. M., Giaccone, G., Hesketh, P. J., Jaiyesimi, I., Leighl, N. B., Riely, G. J., Schiller, J. H., Schneider, B. J., Tashbar, J., Temin, S. & Masters, G., Dec 2017, In : Journal of Oncology Practice. 13, 12, p. 780-783 4 p.

Research output: Contribution to journalReview article

1 Scopus citations
10 Scopus citations
59 Scopus citations

Long-term toxicity of cisplatin in germ-cell tumor survivors

Chovanec, M., Abu Zaid, M., Hanna, N., El-Kouri, N., Einhorn, L. H. & Albany, C., 2017, In : Annals of Oncology. 28, 11, p. 2670-2679 10 p.

Research output: Contribution to journalReview article

50 Scopus citations

Lung cancer screening: what do long-term smokers know and believe?

Carter-Harris, L., Ceppa, D. K. P., Hanna, N. & Rawl, S. M., Feb 1 2017, In : Health Expectations. 20, 1, p. 59-68 10 p.

Research output: Contribution to journalArticle

47 Scopus citations

Phase i Study of Amrubicin and Cyclophosphamide in Patients with Advanced Solid Organ Malignancies

Jalal, S. I., Hanna, N., Zon, R., Masters, G. A., Borghaei, H., Koneru, K., Badve, S., Prasad, N., Somaiah, N., Wu, J., Yu, Z. & Einhorn, L., Jan 1 2017, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 40, 4, p. 329-335 7 p.

Research output: Contribution to journalArticle

Practice makes perfect: The rest of the story in testicular cancer as a model curable neoplasm

Tandstad, T., Kollmannsberger, C. K., Roth, B. J., Jeldres, C., Gillessen, S., Fizazi, K., Daneshmand, S., Lowrance, W. T., Hanna, N. H., Albany, C., Foster, R., Cedermark, G. C., Feldman, D. R., Powles, T., Lewis, M. A., Grimison, P. S., Bank, D., Porter, C., Albers, P., De Santis, M. & 3 others, Srinivas, S., Bosl, G. J. & Nichols, C. R., Nov 1 2017, In : Journal of Clinical Oncology. 35, 31, p. 3525-3528 4 p.

Research output: Contribution to journalComment/debate

25 Scopus citations

Second-Line Chemotherapy and Beyond for Non–Small Cell Lung Cancer

Durm, G. & Hanna, N., Feb 1 2017, In : Hematology/Oncology Clinics of North America. 31, 1, p. 71-81 11 p.

Research output: Contribution to journalReview article

6 Scopus citations

Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial

Lesaffre, E., Edelman, M. J., Hanna, N. H., Park, K., Thatcher, N., Willemsen, S., Gaschler-Markefski, B., Kaiser, R. & Manegold, C., Jul 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 7, p. 1419-1426 8 p.

Research output: Contribution to journalArticle

5 Scopus citations

Systemic therapy for stage IV non-small-cell lung cancer: American society of clinical oncology clinical practice guideline update summary

Hanna, N., Johnson, D., Temin, S. & Masters, G., Dec 2017, In : Journal of Oncology Practice. 13, 12, p. 832-837 6 p.

Research output: Contribution to journalReview article

26 Scopus citations

Systemic therapy for stage IV non–small-cell lung cancer: American Society of clinical oncology clinical practice guideline update

Hanna, N., Johnson, D., Temin, S., Baker, S., Brahmer, J., Ellis, P. M., Giaccone, G., Hesketh, P. J., Jaiyesimi, I., Leighl, N. B., Riely, G. J., Schiller, J. H., Schneider, B. J., Smith, T. J., Tashbar, J., Biermann, W. A. & Masters, G., Oct 20 2017, In : Journal of Clinical Oncology. 35, 30, p. 3484-3515 32 p.

Research output: Contribution to journalArticle

242 Scopus citations

Targeting FGFR in Squamous Cell Carcinoma of the Lung

Hashemi-Sadraei, N. & Hanna, N., Jul 6 2017, (Accepted/In press) In : Targeted Oncology. p. 1-15 15 p.

Research output: Contribution to journalArticle

6 Scopus citations

Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens

Harari, S. E., Sassoon, D. J., Priemer, D. S., Jacob, J. M., Eble, J. N., Caliò, A., Grignon, D. J., Idrees, M., Albany, C., Masterson, T. A., Hanna, N. H., Foster, R. S., Ulbright, T. M., Einhorn, L. H. & Cheng, L., Oct 2017, In : Urologic Oncology: Seminars and Original Investigations. 35, 10, p. 605.e9-605.e16

Research output: Contribution to journalArticle

7 Scopus citations

Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer

Gaschler-Markefski, B., Sikken, P., Heymach, J. V., Gottfried, M., Mellemgaard, A., Novello, S., Gann, C. N., Barrueco, J., Reck, M., Hanna, N. H. & Kaiser, R., Apr 2017, In : ESMO Open. 2, 1, e000102.

Research output: Contribution to journalArticle

8 Scopus citations

TMPRSS2-ERG Fusion in an Uncommon Presentation of Prostate Cancer

Adra, N., Cheng, L., Hanna, N. H. & Durm, G., Jun 2017, In : Clinical Genitourinary Cancer. 15, 3, p. e489-e491

Research output: Contribution to journalArticle

2016
3 Scopus citations

A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors

Necchi, A., Pond, G. R., Nicolai, N., Giannatempo, P., Raggi, D., Adra, N., Hanna, N., Salvioni, R., Einhorn, L. & Albany, C., May 26 2016, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

10 Scopus citations

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

Radovich, M., Kiel, P. J., Nance, S. M., Niland, E. E., Parsley, M. E., Ferguson, M. E., Jiang, G., Ammakkanavar, N. R., Einhorn, L. H., Cheng, L., Nassiri, M., Davidson, D. D., Rushing, D. A., Loehrer, P. J., Pili, R., Hanna, N., Thomas Callaghan, J., Skaar, T. C., Helft, P. R., Shahda, S. & 2 others, O'Neil, B. H. & Schneider, B. P., 2016, In : Oncotarget. 7, 35, p. 56491-56500 10 p.

Research output: Contribution to journalArticle

38 Scopus citations

Management of stage I testicular germ cell tumours

Chovanec, M., Hanna, N., Cary, K. C., Einhorn, L. & Albany, C., Nov 1 2016, In : Nature Reviews Urology. 13, 11, p. 663-673 11 p.

Research output: Contribution to journalReview article

31 Scopus citations

Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial

Hanna, N. H., Kaiser, R., Sullivan, R. N., Aren, O. R., Ahn, M. J., Tiangco, B., Voccia, I., Pawel, J. V., Kovcin, V., Agulnik, J., Gaschler-Markefski, B., Barrueco, J., Sikken, P., Schloss, C. & Kim, J. H., Dec 1 2016, In : Lung Cancer. 102, p. 65-73 9 p.

Research output: Contribution to journalArticle

46 Scopus citations

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study

Adra, N., Albany, C., Brames, M. J., Case-Eads, S., Johnson, C. S., Liu, Z., Fausel, C. A., Breen, T., Hanna, N. H., Hauke, R. J., Picus, J. & Einhorn, L. H., Jul 1 2016, In : Supportive Care in Cancer. 24, 7, p. 2837-2842 6 p.

Research output: Contribution to journalArticle

5 Scopus citations

Prognostic factors in patients with poor-risk germ-cell tumors: A retrospective analysis of the Indiana University experience from 1990 to 2014

Adra, N., Althouse, S. K., Liu, H., Brames, M. J., Hanna, N. H., Einhorn, L. H. & Albany, C., May 1 2016, In : Annals of Oncology. 27, 5, p. 875-879 5 p., 10.1093/annonc/mdw052.

Research output: Contribution to journalArticle

22 Scopus citations
26 Scopus citations